Mitogen-activated protein kinase-interacting protein 1 (MAPKIP1) (MAPKIP1)

Mitogen-activated protein kinase-interacting protein 1 (MAPKIP1), widely known as JIP1, is a vital scaffold protein that coordinates the c-Jun N-terminal kinase (JNK) signaling cascade. By physically tethering JNK with its upstream activators, such as MKK7 and MLK family kinases, MAPKIP1 ensures the specificity and efficiency of signal transduction in response to cellular stress (UniProt Q9UQF2). Beyond its role as a scaffold, it acts as an adaptor for kinesin-1, facilitating the transport of molecular cargo, including the amyloid precursor protein (APP), along axons in neurons (PubMed: 11096150). In clinical contexts, MAPKIP1 is a significant factor in metabolic and neurological pathologies. Mutations in the gene are linked to the development of Type 2 diabetes due to its role in pancreatic beta-cell survival (PubMed: 11239474). In neurobiology, it is implicated in Alzheimer's disease and neuronal apoptosis following ischemic stroke, as it regulates the JNK-mediated death pathway. Therapeutic targeting of MAPKIP1 often involves peptide-based inhibitors like XG-102 (Brimapitide), which mimics the JNK-binding domain of JIP1 to block JNK activation, thereby providing neuroprotection and improving metabolic outcomes in experimental models (PubMed: 19164102).

Other names

JNK-interacting protein 1JIP-1Islet-brain 1IB1Mitogen-activated protein kinase 8-interacting protein 1MAPK8IP1PRKM8IP

Competitive inhibition of the JNK-binding domain to prevent JNK activation and subsequent pro-apoptotic signaling.